{"ModuleTitle": "Company Description", "CompanyName": "Endo International plc", "Symbol": "ENDP", "Address": "1400 ATWATER DRIVE, MALVERN, Pennsylvania, 19355, United States of America", "Phone": "4842160000", "Industry": "Major Pharmaceuticals", "Sector": "Health Care", "Region": "Europe", "CompanyDescription": "Unless otherwise indicated or required by the context, references throughout to\r\n\"Endo,\" the \"Company,\" \"we,\" \"our\" or \"us\" refer to financial information and\r\ntransactions of Endo International plc and its subsidiaries.\r\nEndo International plc is an Ireland-domiciled specialty branded and generics\r\npharmaceutical company. Endo International plc was incorporated in Ireland in\r\n2013 as a private limited company and re-registered effective February 18, 2014\r\nas a public limited company. Endo International plc is a holding company that\r\nconducts its operations through its subsidiaries.\r\nOur ordinary shares are traded on the Nasdaq Global Select Market (NASDAQ) under\r\nthe ticker symbol \"ENDP.\" References throughout to \"ordinary shares\" refer to\r\nEndo International plc's ordinary shares (1,000,000,000 authorized, par value of\r\n$0.0001 per share). In addition, we have 4,000,000 euro deferred shares\r\noutstanding (par value of $0.01 per share).&nbsp;&nbsp;... <a href=\"http://secfilings.nasdaq.com/edgar_conv_html%2f2020%2f02%2f26%2f0001593034-20-000019.html#FIS_BUSINESS\" target=\"_blank\">More</a> ...&nbsp;&nbsp;\r\n", "KeyExecutives": [{"name": "Blaise Coleman", "title": "President, Chief Executive Officer & Director"}, {"name": "Mark Bradley", "title": "Chief Financial Officer & Executive Vice President"}, {"name": "Ruth Thorpe", "title": "Chief Information Officer"}, {"name": "Terrance J. Coughlin", "title": "Chief Operating Officer & Executive Vice President"}], "Number_of_employees": ["2,910"], "Subsidiaries": ["NO INFO"]}